A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma
Phase 1 Completed
43 enrolled
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 1 Unknown
75 enrolled
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
24 enrolled 21 charts
A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
Phase 1 Completed
68 enrolled 26 charts
Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents
Phase 1 Withdrawn
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Phase 1 Terminated
4 enrolled 8 charts
Study of Oral Palifosfamide Tris in Solid Tumors
Phase 1 Suspended
20 enrolled